Back to search
NSCLC Harboring NRG1 Fusion
Clinical trial pipeline · Data from ClinicalTrials.gov
See which NSCLC Harboring NRG1 Fusion trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which NSCLC Harboring NRG1 Fusion trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase II, open-label, 2-arm, multicenter, international study designed to evaluate the efficacy of zenocutuzumab alone or in combination in patients w…
This is a Phase I/II, open-label, multi-center, multi-national, dose escalation, single agent study to assess the safety, tolerability, PK, PD, immunogenicity a…
This is a phase 1b multi-center, open-label study of HMBD-001 with or without chemotherapy in participants with advanced solid tumors harboring NRG1 gene fusion…
Characteristics of patients with Neuregulin-1 (NRG1) gene fusion-positive solid tumors treated with afatinib, and characteristics of those treated with another…